concentration 8 h later (in that study heparin was used although the authors did not elaborate on that fact) [7] . The phenomenon that enoxaparin might reduce the circulating levels of MCP-1 may be very interesting and potentially useful. It suggests an anti-atherosclerotic effect of this LMWH and yet another use of it. Brain renin-angiotensin system: Is it important in dialysis patients?
Sir, Excessive inter dialytic weight gain (IDWG) is an important clinical problem and portends a poor outcome in haemodialysis patients [1] . Treatment is based on the restriction of salt and water intake. However, the compliance is usually poor and one-third of patients treated with maintenance haemodialysis are chronically overhydrated. The cardiovascular and haemodynamic effects of the peripheral renin-angiotensin system (RAS) are well documented. Conversely, the current knowledge regarding the effects of the brain RAS on blood pressure and thirst is mainly based on experimental studies. It was shown in experimental models that the stimulation of centrally located angiotensin 1 receptors (AT1-R) causes a rise in blood pressure, a release of vasopressin [2], thirst and thereby an increase in salt [3] and water [4] intake. In this respect, the effects of the RAS system on the brain could be important in haemodialysed patients. The brain RAS system upregulation is likely to increase the patients' drinking behaviour, along with an increase in salt and water intake causing excessive IDWG. Therefore, the brain RAS represents a potential target for RAS inhibitors to counteract these centrally related effects.
Dipsogenic activity is mediated only by AT-1 receptors. Brain tissue, with the exception of the circumventricular organs, is separated from the circulation by the blood-brain barrier. AT-1 receptors are widespread in the brain, and their stimulation in circumventricular structures causes drinking and pressor responses. In addition to circumventricular organs, AT1 receptors are also located in the inside compartment of the blood-brain barrier, and the activation of these AT1 receptors also causes drinking and pressor responses [5] .
One is allowed to speculate that inhibiting centrally related effects of brain RAS with lipophilic angiotensin-converting enzyme and/or AT1-R blockers exerts a favourable effect on the IDWG. In a prospective, self-controlled and interventional study that included 30 anuric haemodialysed patients, we compared the IDWG in a period of 3 consecutive months without and with administration of telmisartan. We showed that the IDWG significantly decreased following telmisartan at a dosage of 40 mg/day [6] . These results suggest that the treatment of hypertension in haemodialysed patients with AT1-R inhibitors does not only aim at reducing the blood pressure-a shortterm effect. In the long run, it also diminishes thirst, salt and water intake and hence the extracellular fluid volume and tissue sodium concentrations that are essentially responsible for high blood pressure and left ventricular hypertrophy in these patients. The incidence of biopsy-proven glomerulonephritis in Cairo University, Egypt: a 5-year study Sir, The incidence of biopsy-proven glomerulonephritis (GN) varies in different geographical areas and is affected by socio-economic conditions, race, differences in genetic susceptibility and environmental exposure. Recent studies suggested a changing pattern of incidence of GN in different parts of the world [1,2]. For instance, the incidence of endstage renal disease (ESRD) as a result of focal segmental glomerulosclerosis (FSGS) has increased 11-fold in the past two decades in a recent study [2] . Our study aimed to obtain a comprehensive review of the incidence of biopsy-proven glomerulonephritis in Cairo University, Egypt, over the last 5 years. We analysed the clinical and pathological data of all renal biopsy samples that were obtained during the period from July 2003 to 2008. Age, gender, indication of renal biopsy and the pathological findings were recorded for analysis.
A total of 924 renal biopsy samples were referred for pathological assessment during the period of the study. The monthly incidence of biopsy-proven GN was 15.4 [5, 6] . Our results could be explained by high incidence of lupus nephritis among the study subjects as well as the relatively young age of the study group. Further multicentre studies with larger sample size from different parts of the country would give more accurate information on the incidence and frequency of GNs in Egypt.
(range 13-19). Proliferative GN was reported in 497 cases (53.78%) and non-proliferative GN was reported in 427 cases (46.22%). Lupus nephritis was reported in 264 cases (28.57%). The female/male ratio was 221/41, 70% of lupus patients aged 18-45 years and 85% had renal impairment (mean serum creatinine was 3.21 ± 4.09 mg/dl). The common glomerular pathologies in patients with lupus nephritis were the proliferative classes 30.30, 27.65%, respectively) .
Morphologically, FSGS was the most frequent cause of GN (21.21%) followed by mesangial proliferative GN (18.93%), diffuse proliferative GN (13.96%), focal proliferative GN (12.77%) and membranous GN (10.93%) ( Table 1 ). In females, mesangial proliferative, focal proliferative GN and diffuse proliferative GN were the predominant pathological findings, and in males FSGS, diffuse proliferative GN and mesangial proliferative GN were predominant. In those aged <18, mesangial proliferative GN, minimal change disease and FSGS were more prevalent compared to adults. Figure 1 shows the frequency of GN in patients with renal insufficiency.
